Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We present the surgical implantation of the Edwards Inspiris Resilia® aortic valve in mitral position for mechanical mitral valve failure in a severely ill infant after valve replacement because of anomalous origin of the left coronary artery from the pulmonary artery. The biological valve was chosen because the child could not receive oral anticoagulation and was for several months on heparin infusion. The procedure was safely performed with good haemodynamic result.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S1047951118001816 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Significant transprosthetic cuff leak following aortic valve replacement with an Inspiris Resilia valve resulting in explantation.
J Surg Case Rep
August 2025
Division of Cardiac Surgery, Department of Surgery, SUNY Upstate Medical Center, 739 Irving Ave, Suite 640, Syracuse, NY 13210, United States.
A 77-year-old male presented with symptomatic, severe aortic stenosis, for which he underwent an aortic valve replacement with the Edwards Inspiris Resilia bioprosthetic valve. After removal of the cross-clamp, a greater than mild transprosthetic cuff leak through a defect between the sewing ring and valve stent post was identified on transesophageal echocardiogram leading to the subsequent need for valve explant and new valve implantation.
View Article and Find Full Text PDFMid-Term Outcomes After Aortic Valve Replacement in Patients Under 70: A Comparative Study of INSPIRIS RESILIA Versus PERIMOUNT MAGNA EASE Bioprostheses.
Interdiscip Cardiovasc Thorac Surg
August 2025
Department of Thoracic and Cardiovascular Surgery, Reims University Hospital, 51100 Reims, France.
Objectives: INSPIRIS RESILIA, launched in 2017, is a bioprosthetic aortic valve developed to improve durability and facilitate future valve-in-valve procedures. Despite its advanced design, many surgeons continue to use the PERIMOUNT MAGNA EASE valve, which has long-standing clinical validation. This study aimed to compare mid-term clinical and echocardiographic outcomes in patients under 70 undergoing aortic valve replacement with either prosthesis.
View Article and Find Full Text PDFGender-based outcomes following surgical aortic valve replacement: a multicentre propensity score matching analysis†.
Eur J Cardiothorac Surg
July 2025
Department of Cardiac, Vascular and Thoracic Surgery, Kepler University Hospital Linz, Linz, Austria.
Objectives: This study investigated the gnder-based difference in three-year clinical outcomes, left ventricular (LV) regression, and quality-of-life (QoL) following surgical aortic valve replacement (SAVR) by propensity score matching (PSM).
Methods: A prospective multicentre study on combined data from two prospective registries, INDURE and IMPACT, resulted in 993 patients (735 males and 258 females). PSM yielded 689 patients: 442 males and 247 females undergoing first-time SAVR using Edwards INSPIRIS RESILIA.
Long-term Mechanical Durability of Inspiris RESILIA Surgical Aortic Valves.
Ann Thorac Surg Short Rep
June 2025
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia.
Background: Prolonged mechanical durability and hemodynamic characteristics after durability tests of surgical valves need to be studied. Inspiris RESILIA (Edwards Lifesciences), a relatively recent and novel surgical aortic valve, was evaluated after accelerated wear testing.
Methods: Three 21-mm and 3 23-mm Inspiris valves were cycled in the durability tester for 2 billion cycles (equivalent to 50 years) and were compared with a control valve of respective size.
Predicted vs. Observed Prosthesis-Patient Mismatch After Surgical Aortic Valve Replacement.
Medicina (Kaunas)
April 2025
Cardiac Surgery Unit, Azienda Ospedale Università di Padova, 35122 Padova, Italy.
: Prosthesis-patient mismatch (PPM) after surgical aortic valve replacement (SAVR) is associated with worse clinical outcomes and worse valve durability. The aim of this retrospective single-center study was to evaluate the consistency between predicted PPM (PPMp) and measured PPM (PPMm) after SAVR with three different bioprostheses. : We analyzed data of all consecutive patients who underwent surgical aortic valve replacement with Magna Ease, Intuity, and Inspiris Resilia bioprostheses (Edwards Lifesciences, Irvine, CA, USA) at our institution.
View Article and Find Full Text PDF